Abstract: A compound having a structure as shown in general formula (I), a deuterated compound, a stereoisomer, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising same, and use thereof. The compound has a good PIM kinase inhibitory effect, is a novel and ideal PIM inhibitor having high activity and low toxicity, and can be used for treating and/or preventing hematoma such as acute myeloid leukemia, bone marrow fibrosis and chronic lymphocytic leukemia, solid tumors such as gastric cancer and prostate cancer, and other diseases.

Abstract: In one embodiment, a method includes displaying, by a participant processor on a display device and during an online conference, a list of invited participants of the online conference. The list includes a declining one of the invited participants whom declined to participate in at least a part of the online conference. The method also includes indicating, by the participant processor on the display device and for the one of the invited participants whom declined to participate, a message having a reason for declining.

Abstract: In one embodiment, a method includes displaying, by a participant processor on a display device and during an online conference, a list of invited participants of the online conference. The list includes a declining one of the invited participants whom declined to participate in at least a part of the online conference. The method also includes indicating, by the participant processor on the display device and for the one of the invited participants whom declined to participate, a message having a reason for declining.

Abstract: A method for selecting a compound that modulates the activity of a ribozyme in vivo in an organism comprising: (a) measuring in an assay the ability of a compound to selectively bind to a ribozyme thereby inhibiting the function of said ribozyme; and (b) selecting the assayed compound for use in modulating the activity of said ribozyme in vivo in an organism as a pharmaceutical agent as well as a method for selecting a compound for diagnosing the presence of a ribozyme in an organism that is pathogenic to an animal or plant.